Targeting the glucagon receptor signaling pathway as a novel strategy to counteract PI3K inhibitor induced hyperglycemia while sustaining tumor PI3K inhibition.

Authors	Jie Wang, Takuya Osada, Michael A Morse, Frank Calzone, Hai Yan, Dung Thai, H Kim Lyerly
Journal	Leukemia & lymphoma (Leuk Lymphoma) Vol. 62 Issue 7 Pg. 1761-1764 (07 2021) ISSN: 1029-2403 [Electronic] United States
PMID	33576297 (Publication Type: Letter)
Chemical References	Receptors, Glucagon Glucagon
Topics	Glucagon Humans Hyperglycemia (chemically induced) Neoplasms Phosphatidylinositol 3-Kinases (genetics, metabolism) Receptors, Glucagon (genetics) Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!